News

• ONL Therapeutics Closes $46.9 Million in Series B Financing to Advance ONL1204 into Three Retinal Disease Indications
  12/22/2020 / 13:00 - GlobeNewswire
•  
• project44 Raises $100M to Accelerate Supply Chain Transformation, Expand Advanced Visibility Platform
  12/21/2020 / 15:00 - GlobeNewswire
•  
• Oyster Point Pharma Strengthens Executive Leadership Team with the Appointment of Chief Medical and Chief Scientific Officers
  12/07/2020 / 13:00 - GlobeNewswire
•  
• Matinas BioPharma Appoints Hui Liu, Ph.D., M.B.A. as Chief Technology Officer
  12/01/2020 / 13:00 - GlobeNewswire
•  
• Pixium Vision Hosting Key Opinion Leader Webinar on the Prima System for Atrophic Dry Age-related Macular Degeneration (dry-AMD)
  10/16/2020 / 07:30 - GlobeNewswire
•  
• Publicis Groupe: Third Quarter 2020 Revenue
  10/15/2020 / 07:30 - GlobeNewswire
•  
• Equinox Ophthalmic, Inc. appoints Stuart Raetzman as Executive Chair
  10/07/2020 / 12:00 - GlobeNewswire
•  
• Graybug Appoints Three New Members to its Board of Directors
  09/25/2020 / 14:00 - GlobeNewswire
•  
• Nicox First Half 2020 Financial Results and Business Update
  09/10/2020 / 07:30 - GlobeNewswire
•  
• Agios Appoints Jonathan Biller as Chief Financial Officer, Head of Legal and Corporate Affairs
  09/08/2020 / 22:01 - GlobeNewswire
•  
• Aleafia Health Announces Appointment of Pharmaceutical Executive Tricia Symmes as Chief Commercial Officer
  08/21/2020 / 13:00 - GlobeNewswire
•  
• Wishbone Medical Appoints Jeff George to Board of Directors
  08/12/2020 / 14:01 - GlobeNewswire
•  
• TearClear Raises $22 Million to Advance Multiple Clinical Programs in Development
  08/11/2020 / 13:00 - GlobeNewswire
•  
• Oxurion NV appoints Grace Chang, M.D., Ph.D. as Chief Medical Officer
  08/03/2020 / 08:00 - GlobeNewswire
•  
• Oculis Announces Successful End-of-Phase 2 Meeting with the FDA for OCS-01 in Two Ophthalmology Indications
  07/27/2020 / 14:00 - GlobeNewswire